Document is current
Any future updates will be listed below
-
Authors
Petrova, Tatiana V.
Kuznetzova, Daria V.
Kanygina, Alexandra V.
Skorodumova, Liubov O.
Ivanov, Viktor A.
Astrelina, Tatiana A.
Varlamova, Svetlana E.
Zerkalenkova, Elena A.
Sharova, Elena I.
-
Funding
Funding for this research was provided by:
Federal Medical Biological Agency («T-kletki» 123032900030-7)
Federal Medical Biological Agency («T-kletki» 123032900030-7)
Federal Medical Biological Agency («T-kletki» 123032900030-7)
Federal Medical Biological Agency («T-kletki» 123032900030-7)
Federal Medical Biological Agency («T-kletki» 123032900030-7)
Federal Medical Biological Agency («T-kletki» 123032900030-7)
- License Information
-
More Information
Article History
Received: 6 June 2025
Accepted: 17 November 2025
First Online: 24 November 2025
Declarations
:
: The authors declare no competing interests.
: For tumor and blood samples from a patient this study was approved by the local institutional review board of the Burnasyan Federal Medical Biophysical Center FMBA of Russia under protocol RU-FMBC-23-07-2020. The study was conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from the patient prior to his participation. Animal procedures were approved by the local institutional review board of the Vivarium of the Department of Experimental Biology at the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences (IBCh RAS) under protocol #378/2023 and carried out in accordance with the institutional guidelines.
